Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab

By sjmartinez • May 13, 2025

Kim GH, Zhang X, Brown MS, Poole L, Goldin J. Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab. BMJ Open. 2025 May 12;15(5):e094559. doi: 10.1136/bmjopen-2024-094559. PMID: 40355288.

Tags: Chest imaging, Computed tomography, interstitial lung disease, Patient reported outcome measures, Publications, Pulmonary Disease, Pulmonary, Critical Care & Sleep Medicine, QUALITATIVE RESEARCH

Biological sex differences in the United States CTEPH Registry

Cirulis MM, Auger WR, Benza RL, Channick RN, Chin K, Davis RD, Elliott CG, He F, Jain S, LaCroix AZ, Madani MM, McLaughlin V, Tapson[...]

Social and clinical determinants of liver transplant evaluation in hepatocellular carcinoma: A multicenter cohort study

Tincopa M, Bridi L, Vodkin I, Yilma M, Zhou K, Kwong A, Singh J, Mehta N, Kuo A, Hirose R, Wisel SA, Steggerda JA, Freise[...]

Gender Minority Stress and Resilience Factors Associated With Persistent Depressive Symptoms Among Transgender and Gender Diverse Adolescents and Young Adults Accessing Gender-Affirming Medical Care

Conn BM, Durazo-Arvizu R, Wong CF, West AE, Chen D, Chan YM, Ehrensaft D, Garofalo R, Hidalgo MA, Rosenthal SM, Olson-Kennedy J. Gender Minority Stress[...]